Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

CD44-associated radioresistance of glioblastoma in irradiated brain areas with optimal tumor coverage.

Liu WH, Lin JC, Chou YC, Li MH, Tsai JT.

Cancer Med. 2020 Jan;9(1):350-360. doi: 10.1002/cam4.2714. Epub 2019 Nov 19.

2.

MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.

Lin JC, Tsai JT, Chao TY, Ma HI, Chien CS, Liu WH.

Radiother Oncol. 2018 Nov;129(2):352-363. doi: 10.1016/j.radonc.2018.09.014. Epub 2018 Oct 12.

PMID:
30322656
3.

The STAT3/Slug Axis Enhances Radiation-Induced Tumor Invasion and Cancer Stem-like Properties in Radioresistant Glioblastoma.

Lin JC, Tsai JT, Chao TY, Ma HI, Liu WH.

Cancers (Basel). 2018 Dec 13;10(12). pii: E512. doi: 10.3390/cancers10120512.

4.

Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase.

Carruthers R, Ahmed SU, Strathdee K, Gomez-Roman N, Amoah-Buahin E, Watts C, Chalmers AJ.

Mol Oncol. 2015 Jan;9(1):192-203. doi: 10.1016/j.molonc.2014.08.003. Epub 2014 Aug 24.

5.

Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures.

Gonçalves DPN, Rodriguez RD, Kurth T, Bray LJ, Binner M, Jungnickel C, Gür FN, Poser SW, Schmidt TL, Zahn DRT, Androutsellis-Theotokis A, Schlierf M, Werner C.

Acta Biomater. 2017 Aug;58:12-25. doi: 10.1016/j.actbio.2017.05.054. Epub 2017 May 31.

PMID:
28576716
6.

Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.

Song WS, Yang YP, Huang CS, Lu KH, Liu WH, Wu WW, Lee YY, Lo WL, Lee SD, Chen YW, Huang PI, Chen MT.

J Chin Med Assoc. 2016 Oct;79(10):538-45. doi: 10.1016/j.jcma.2016.03.010. Epub 2016 Aug 13.

7.

Radiation-Induced Changes in Tumor Vessels and Microenvironment Contribute to Therapeutic Resistance in Glioblastoma.

Seo YS, Ko IO, Park H, Jeong YJ, Park JA, Kim KS, Park MJ, Lee HJ.

Front Oncol. 2019 Nov 15;9:1259. doi: 10.3389/fonc.2019.01259. eCollection 2019.

8.

PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.

Cenciarelli C, Marei HE, Zonfrillo M, Pierimarchi P, Paldino E, Casalbore P, Felsani A, Vescovi AL, Maira G, Mangiola A.

Mol Cancer. 2014 Nov 8;13:247. doi: 10.1186/1476-4598-13-247.

9.

AHIF promotes glioblastoma progression and radioresistance via exosomes.

Dai X, Liao K, Zhuang Z, Chen B, Zhou Z, Zhou S, Lin G, Zhang F, Lin Y, Miao Y, Li Z, Huang R, Qiu Y, Lin R.

Int J Oncol. 2019 Jan;54(1):261-270. doi: 10.3892/ijo.2018.4621. Epub 2018 Nov 2.

PMID:
30387845
10.

Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.

Ning S, Knox SJ.

Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):197-203.

PMID:
15337556
11.

Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.

Clark PA, Bhattacharya S, Elmayan A, Darjatmoko SR, Thuro BA, Yan MB, van Ginkel PR, Polans AS, Kuo JS.

J Neurosurg. 2017 May;126(5):1448-1460. doi: 10.3171/2016.1.JNS152077. Epub 2016 Jul 15.

12.

Transcranial sonography: integration into target volume definition for glioblastoma multiforme.

Vordermark D, Becker G, Flentje M, Richter S, Goerttler-Krauspe I, Koelbl O.

Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):565-71.

PMID:
10837937
13.

Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.

Kim SS, Harford JB, Pirollo KF, Chang EH.

Biochem Biophys Res Commun. 2015 Dec 18;468(3):485-9. doi: 10.1016/j.bbrc.2015.06.137. Epub 2015 Jun 24. Review.

14.

Radioresistance of mesenchymal glioblastoma initiating cells correlates with patient outcome and is associated with activation of inflammatory program.

Stanzani E, Martínez-Soler F, Mateos TM, Vidal N, Villanueva A, Pujana MA, Serra-Musach J, de la Iglesia N, Giménez-Bonafé P, Tortosa A.

Oncotarget. 2017 Jun 3;8(43):73640-73653. doi: 10.18632/oncotarget.18363. eCollection 2017 Sep 26.

15.

Irradiation induces glioblastoma cell senescence and senescence-associated secretory phenotype.

Jeon HY, Kim JK, Ham SW, Oh SY, Kim J, Park JB, Lee JY, Kim SC, Kim H.

Tumour Biol. 2016 May;37(5):5857-67. doi: 10.1007/s13277-015-4439-2. Epub 2015 Nov 19.

PMID:
26586398
16.

Glioblastoma specific antigens, GD2 and CD90, are not involved in cancer stemness.

Woo SR, Oh YT, An JY, Kang BG, Nam DH, Joo KM.

Anat Cell Biol. 2015 Mar;48(1):44-53. doi: 10.5115/acb.2015.48.1.44. Epub 2015 Mar 20.

17.

Dual blockage of STAT3 and ERK1/2 eliminates radioresistant GBM cells.

Xie B, Zhang L, Hu W, Fan M, Jiang N, Duan Y, Jing D, Xiao W, Fragoso RC, Lam KS, Sun LQ, Li JJ.

Redox Biol. 2019 Jun;24:101189. doi: 10.1016/j.redox.2019.101189. Epub 2019 Apr 9.

18.

FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.

Maachani UB, Shankavaram U, Kramp T, Tofilon PJ, Camphausen K, Tandle AT.

Oncotarget. 2016 Nov 22;7(47):77365-77377. doi: 10.18632/oncotarget.12670.

19.

TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.

Ghosh D, Ulasov IV, Chen L, Harkins LE, Wallenborg K, Hothi P, Rostad S, Hood L, Cobbs CS.

Stem Cells. 2016 Sep;34(9):2276-89. doi: 10.1002/stem.2411. Epub 2016 Jul 4.

20.

Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients.

Howard CM, Valluri J, Alberico A, Julien T, Mazagri R, Marsh R, Alastair H, Cortese A, Griswold M, Wang W, Denning K, Brown L, Claudio PP.

Transl Oncol. 2017 Apr;10(2):241-254. doi: 10.1016/j.tranon.2017.01.008. Epub 2017 Feb 12.

Supplemental Content

Support Center